Cover Image
Market Research Report
Product code 
1044382

Global Regulatory Affairs Outsourcing Market 2022-2026

Published: | TechNavio (Infiniti Research Ltd.) | 120 Pages | Delivery time: 1-2 business days

Price

Back to Top
Global Regulatory Affairs Outsourcing Market 2022-2026
Published: December 1, 2021
TechNavio (Infiniti Research Ltd.)
Content info: 120 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents

Technavio has been monitoring the regulatory affairs outsourcing market and it is poised to grow by $ 4.63 bn during 2022-2026, progressing at a CAGR of 12.15% during the forecast period. Our report on the regulatory affairs outsourcing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growth of the pharmaceutical industry and the availability of cost-efficient resources in emerging markets. In addition, the growth of the pharmaceutical industry is anticipated to boost the growth of the market as well.

The regulatory affairs outsourcing market analysis includes the end-user segment and geographic landscape.

Technavio's regulatory affairs outsourcing market is segmented as below:

By End-user

  • Pharmaceutical
  • Medical device
  • Biotechnology

By Geographical Landscape

  • APAC
  • North America
  • Europe
  • ROW

This study identifies the high regulatory compliance associated with healthcareas one of the prime reasons driving the regulatory affairs outsourcing market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on regulatory affairs outsourcing market covers the following areas:

  • Regulatory affairs outsourcing market sizing
  • Regulatory affairs outsourcing market forecast
  • Regulatory affairs outsourcing market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading regulatory affairs outsourcing market vendors that include Certara Inc., Charles River Laboratories International Inc., Genpact Ltd., Icon Plc, Laboratory Corp. of America Holdings, Medpace Holdings Inc., PPD Inc., PRA Health Sciences Inc., ProPharma Group Holdings LLC, and WuXi AppTec Co. Ltd. Also, the regulatory affairs outsourcing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR71647

Table of Contents

  • Executive Summary
    • Market Overview
  • Market Landscape
    • Market ecosystem
    • Value chain analysis
  • Market Sizing
    • Market definition
    • Market segment analysis
    • Market size 2021
    • Market outlook: Forecast for 2021 - 2026
  • Five Forces Analysis
    • Bargaining power of buyers
    • Bargaining power of suppliers
    • Threat of new entrants
    • Threat of substitutes
    • Threat of rivalry
    • Market condition
  • Market Segmentation by End-user
    • Market segments
    • Comparison by End-user
    • Pharmaceutical - Market size and forecast 2021-2026
    • Medical device - Market size and forecast 2021-2026
    • Biotechnology - Market size and forecast 2021-2026
    • Market opportunity by End-user
  • Customer landscape
  • Geographic Landscape
    • Geographic segmentation
    • Geographic comparison
    • APAC - Market size and forecast 2021-2026
    • North America - Market size and forecast 2021-2026
    • Europe - Market size and forecast 2021-2026
    • ROW - Market size and forecast 2021-2026
    • Key leading countries
    • Market opportunity By Geographical Landscape
    • Market drivers
    • Market challenges
    • Market trends
  • Vendor Landscape
    • Landscape disruption
  • Vendor Analysis
    • Vendors covered
    • Market positioning of vendors
    • Certara Inc.
    • Charles River Laboratories International Inc.
    • Genpact Ltd.
    • Icon Plc
    • Laboratory Corp. of America Holdings
    • Medpace Holdings Inc.
    • PPD Inc.
    • PRA Health Sciences Inc.
    • ProPharma Group Holdings LLC
    • WuXi AppTec Co. Ltd.
  • Appendix
    • Scope of the report
    • Currency conversion rates for US$
    • Research methodology
    • List of abbreviations

Exhibits

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2021 - 2026 ($ million)
  • 13: Global market: Year-over-year growth 2021 - 2026 (%)
  • 14: Five forces analysis 2021 & 2026
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2021
  • 21: End-user - Market share 2021-2026 (%)
  • 22: Comparison by End-user
  • 23: Pharmaceutical - Market size and forecast 2021-2026 ($ million)
  • 24: Pharmaceutical - Year-over-year growth 2021-2026 (%)
  • 25: Medical device - Market size and forecast 2021-2026 ($ million)
  • 26: Medical device - Year-over-year growth 2021-2026 (%)
  • 27: Biotechnology - Market size and forecast 2021-2026 ($ million)
  • 28: Biotechnology - Year-over-year growth 2021-2026 (%)
  • 29: Market opportunity by End-user
  • 30: Customer landscape
  • 31: Market share By Geographical Landscape 2021-2026 (%)
  • 32: Geographic comparison
  • 33: APAC - Market size and forecast 2021-2026 ($ million)
  • 34: APAC - Year-over-year growth 2021-2026 (%)
  • 35: North America - Market size and forecast 2021-2026 ($ million)
  • 36: North America - Year-over-year growth 2021-2026 (%)
  • 37: Europe - Market size and forecast 2021-2026 ($ million)
  • 38: Europe - Year-over-year growth 2021-2026 (%)
  • 39: ROW - Market size and forecast 2021-2026 ($ million)
  • 40: ROW - Year-over-year growth 2021-2026 (%)
  • 41: Key leading countries
  • 42: Market opportunity By Geographical Landscape ($ million)
  • 43: Impact of drivers and challenges
  • 44: Vendor landscape
  • 45: Landscape disruption
  • 46: Industry risks
  • 47: Vendors covered
  • 48: Market positioning of vendors
  • 49: Certara Inc. - Overview
  • 50: Certara Inc. - Product and service
  • 51: Certara Inc. - Key offerings
  • 52: Certara Inc. - Key customers
  • 53: Certara Inc. - Segment focus
  • 54: Charles River Laboratories International Inc. - Overview
  • 55: Charles River Laboratories International Inc. - Business segments
  • 56: Charles River Laboratories International Inc. - Key offerings
  • 57: Charles River Laboratories International Inc. - Key customers
  • 58: Charles River Laboratories International Inc. - Segment focus
  • 59: Genpact Ltd. - Overview
  • 60: Genpact Ltd. - Business segments
  • 61: Genpact Ltd. - Key offerings
  • 62: Genpact Ltd. - Key customers
  • 63: Genpact Ltd. - Segment focus
  • 64: Icon Plc - Overview
  • 65: Icon Plc - Product and service
  • 66: Icon Plc - Key offerings
  • 67: Icon Plc - Key customers
  • 68: Icon Plc - Segment focus
  • 69: Laboratory Corp. of America Holdings - Overview
  • 70: Laboratory Corp. of America Holdings - Business segments
  • 71: Laboratory Corp. of America Holdings - Key offerings
  • 72: Laboratory Corp. of America Holdings - Key customers
  • 73: Laboratory Corp. of America Holdings - Segment focus
  • 74: Medpace Holdings Inc. - Overview
  • 75: Medpace Holdings Inc. - Business segments
  • 76: Medpace Holdings Inc. - Key offerings
  • 77: Medpace Holdings Inc. - Key customers
  • 78: Medpace Holdings Inc. - Segment focus
  • 79: PPD Inc. - Overview
  • 80: PPD Inc. - Product and service
  • 81: PPD Inc. - Key offerings
  • 82: PPD Inc. - Key customers
  • 83: PPD Inc. - Segment focus
  • 84: PRA Health Sciences Inc. - Overview
  • 85: PRA Health Sciences Inc. - Business segments
  • 86: PRA Health Sciences Inc. - Key offerings
  • 87: PRA Health Sciences Inc. - Key customers
  • 88: PRA Health Sciences Inc. - Segment focus
  • 89: ProPharma Group Holdings LLC - Overview
  • 90: ProPharma Group Holdings LLC - Product and service
  • 91: ProPharma Group Holdings LLC - Key offerings
  • 92: ProPharma Group Holdings LLC - Key customers
  • 93: ProPharma Group Holdings LLC - Segment focus
  • 94: WuXi AppTec Co. Ltd. - Overview
  • 95: WuXi AppTec Co. Ltd. - Business segments
  • 96: WuXi AppTec Co. Ltd. - Key offerings
  • 97: WuXi AppTec Co. Ltd. - Key customers
  • 98: WuXi AppTec Co. Ltd. - Segment focus
  • 99: Currency conversion rates for US$
  • 100: Research Methodology
  • 101: Validation techniques employed for market sizing
  • 102: Information sources
  • 103: List of abbreviations